Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D.
D004359:Drug Therapy, Combination; D005260:Female; D005459:Fluorides / Q000009:adverse effects*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000097:blood; D008875:Middle Aged; D010018:Osteomalacia / Q000139:chemically induced*; D010024:Osteoporosis / Q000188:drug therapy*; D012969:Sodium Fluoride / Q000009:adverse effects* / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use*
D006887:Hydroxycholecalciferols; D014807:Vitamin D; D012969:Sodium Fluoride; D005459:Fluorides